© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
ARTICLE |
Effectiveness of Implementing the Agency for Healthcare Research and Quality Smoking Cessation Clinical Practice Guideline: A Randomized, Controlled Trial
For the AHRQ Smoking Cessation Guideline Study Group
Affiliations of authors: Departments of Medicine (DAK, DRM, MCF), Population Health Sciences (DAK), Nursing (RLB), Psychology (TBB), and the Center for Tobacco Research and Intervention (MCF, TBB), University of Wisconsin, Madison
Correspondence to: David A. Katz, MD, MSc, University of Iowa Hospital and Clinics, SE618-GH, 200 Hawkins Dr., Iowa City, IA 52242 (e-mail: david-katz{at}uiowa.edu)
Background: The Agency for Healthcare Research and Quality (AHRQ) Smoking Cessation Clinical Practice Guideline recommends that all clinicians strongly advise their patients who use tobacco to quit. Methods: We conducted a randomized, controlled trial of the effectiveness of Guideline implementation at eight community-based primary care clinics in southern Wisconsin (four test sites, four control sites) among 2163 consecutively enrolled adult patients who smoked at least one cigarette per day and presented for nonemergency care during the baseline period (June 16, 1999, to June 20, 2000) or the intervention period (from June 21, 2000, to May 3, 2001). After collecting baseline data, staff at test sites implemented the intervention over a 2-month period. The intervention included a tutorial for intake clinicians, group and individual performance feedback for intake clinicians, use of a modified vital signs stamp, an offer of free nicotine replacement therapy, and proactive telephone counseling. Staff at control sites received only general information about the AHRQ Guideline. Self-reported abstinence from smoking was determined by telephone interviews at 2- and 6-month follow-up assessments. Hierarchical logistic regression models were used to estimate the odds ratios (ORs) for treatment assignment after adjustment for patient characteristics. All statistical tests were two-sided. Results: There were no statistically significant differences in smoking cessation rates between participants at test and control sites during the baseline period. Among participants treated during the intervention period, those at test sites were more likely than those at control sites to report being abstinent at the 2-month (16.4% versus 5.8%; adjusted OR = 3.3, 95% confidence interval [CI] = 1.9 to 5.6; P<.001) and 6-month (15.4% versus 9.8%; adjusted OR = 1.7, 95% CI = 1.2 to 2.6; P = .009) follow-up assessments and to report continuous abstinence, that is, abstinence at both 2 and 6 months (10.9% versus 3.8%; adjusted OR = 3.4, 95% CI = 1.8 to 6.3; P<.001). Conclusion: Implementation of a guideline-based smoking cessation intervention by intake clinicians in primary care is associated with higher abstinence among smokers.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- Tobacco Control in the Physician’s Office: A Matter of Adequate Training and Resources
- Robert A. Schnoll and Paul F. Engstrom
J Natl Cancer Inst 2004 96: 573-575.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  D. M. Murray, S. L. Pals, J. L. Blitstein, C. M. Alfano, and J. Lehman Design and Analysis of Group-Randomized Trials in Cancer: A Review of Current Practices J Natl Cancer Inst, April 2, 2008; 100(7): 483 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Wadland, J. S. Holtrop, D. Weismantel, P. K. Pathak, H. Fadel, and J. Powell Practice-Based Referrals to a Tobacco Cessation Quit Line: Assessing the Impact of Comparative Feedback vs General Reminders Ann. Fam. Med, March 1, 2007; 5(2): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Roth-Cline Clinical Trials in the Wake of Vioxx: Requiring Statistically Extreme Evidence of Benefit to Ensure the Safety of New Drugs Circulation, May 9, 2006; 113(18): 2253 - 2259. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Winickoff, S. E. Tanski, R. C. McMillen, B. J. Hipple, J. Friebely, and E. A. Healey A National Survey of the Acceptability of Quitlines to Help Parents Quit Smoking Pediatrics, April 1, 2006; 117(4): e695 - e700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Dell, S. Whitman, A. M. Shah, A. Silva, and D. Ansell Smoking in 6 Diverse Chicago Communities--A Population Study Am J Public Health, June 1, 2005; 95(6): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Eyre, R. Kahn, R. M. Robertson, and and the ACS/ADA/AHA Collaborative Writing Committe Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Stroke, August 1, 2004; 35(8): 1999 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Eyre, R. Kahn, R. M. Robertson, and the ACS/ADA/AHA Collaborative Writing Committe, N. G. Clark, C. Doyle, T. Gansler, T. Glynn, Y. Hong, R. A. Smith, et al. Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association CA Cancer J Clin, July 1, 2004; 54(4): 190 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Eyre, R. Kahn, and R. M. Robertson Preventing Cancer, Cardiovascular Disease, and Diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Diabetes Care, July 1, 2004; 27(7): 1812 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Eyre, R. Kahn, R. M. Robertson, the ACS/ADA/AHA Collaborative Writing Committee, ACS/ADA/AHA Collaborative Writing Committee Member, N. G. Clark, C. Doyle, Y. Hong, T. Gansler, T. Glynn, et al. Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Circulation, June 29, 2004; 109(25): 3244 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Schnoll and P. F. Engstrom Tobacco Control in the Physician's Office: A Matter of Adequate Training and Resources J Natl Cancer Inst, April 21, 2004; 96(8): 573 - 575. [Full Text] [PDF]
|
|